Answers are grounded in this paper and cite their sources.
Examines the link between glucocerebrosidase activity and cognition in Parkinson's Disease, suggesting limited biomarker potential.
Monocytic GCase activity does not appear to be a reliable biomarker for cognitive decline in early-stage PD and is not linked to regional cholinergic denervation. Peripheral measurements do not reflect central processes underlying cholinergic dysfunction.
No takes yet. Share an insight, caveat, or question.
Slingerland et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: